SII is pursuing approval for the Covishield as a booster dose due to concerns of Omicron
SII requested clearance for the Covishield vaccination as a booster dosage, claiming that the vaccine is in sufficient…
Bharat Biotech has submitted Covaxin’s Phase III trial data to DCGI: Govt sources
The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin
First batch of drug 2-DG expected to be launched next week for COVID patients
The first batch of drug 2-Deoxy-D-Glucose is expected to be launched next week for the COVID patients. The…
DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old
The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of…
Regulator gives nod to emergency use of DRDO’s Anti-Covid drug, that will come in powder form
The Drugs Controller General of India (DCGI) on Saturday approved the emergency use of an anti-Covid oral drug…